Kuehne+Nagel will distribute Moderna’s vaccine

January 12, 2021

Agreement allows for international distribution and storage

Moderna and Kuehne+Nagel have reached an international supply chain arrangement to provide distribution and storage of Moderna’s Covid-19 mRNA vaccine. The news comes after the vaccine was granted conditional market authorization (CMA) by the European Commission last week.

The arrangement includes distribution and warehousing of the vaccine from Kuehne+Nagel’s Europe-based pharma hub. The logistics company will use its network of more than 230 operations worldwide to distribute the vaccine via road and air. In Europe, the company operates its own fleet of over 200 dedicated pharma transport vehicles—besides this region, distribution will also be to Asia, the Middle East and parts of the Americas. At all stages of transport and storage, product temperature will remain at the required -20°C (-4°F).

Kuehne+Nagel has also signed partnerships with officials in various countries for local storage and last-mile distribution, including in Germany’s most populous state, North Rhine-Westphalia.